Extended Data Fig. 1: Clinical features and outcomes. | Nature Cancer

Extended Data Fig. 1: Clinical features and outcomes.

From: Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

Extended Data Fig. 1

Clinical impact of sex (a, Female n = 31, Male n = 18), Race (b, African Americans n = 4, White n = 38), age (c,  < 65 years n = 37; >65 years n = 12), Isotype (d, IgG n = 30; IgG 30; Light chain 9), and ISS (e, ISS1 n = 22, ISS2 n = 24, ISS3 n = 3). PFS: progression free survival; ISS: international scoring system.

Back to article page